| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 28,826 | 26,861 | 32,731 | 40,154 | | Cost of Revenue | 23,087 | 20,677 | 26,853 | 33,686 | | | Gross Profit | 5,739 | 6,184 | 5,878 | 6,468 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,539 | 4,468 | 5,152 | 4,952 | | Non Recurring | 2,123 | (2,066) | (57) | (1,173) | | Others | 1,064 | 1,071 | 1,275 | 1,215 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (786) | 2,711 | (492) | 1,474 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,241 | (1) | 18 | 49 | | Earnings Before Interest And Taxes | (746) | 2,710 | (474) | 1,523 | | Interest Expense | 198 | 354 | 181 | 321 | | Income Before Tax | (944) | 2,356 | (655) | 1,202 | | Income Tax Expense | (244) | 767 | (165) | 194 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (700) | 1,589 | (490) | 1,008 | | | Non-recurring Events | | Discontinued Operations | (282) | (449) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (982) | 1,140 | (490) | 1,008 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($982) | $1,140 | ($490) | $1,008 |
|
0.49% Nasdaq 0.00%
Income Statement
